Session Chair Profile

M.D., Managing Director, BlueCross BlueShield Venture Partners

Tom Hawes serves on the Board of Directors of AbleTo, Octave Bio, Oncology Analytics, Patientco, Upward Health, and Verata as well as board observer for HeartFlow, Healthify, Phreesia, and Thrive Science. He was formerly on the Board of InVivoLink, Nexidia, and Wellspring Healthcare. Before joining Sandbox, Tom matched at Yale School of Medicine for residency and completed his first year of medical training at Greenwich Hospital. During his medical training, he worked on clinical studies at the ISK Institute for Orthopaedics and Sports Medicine and on outcomes research at the National Cancer Institute and NYMC’s Cardiothoracic Surgery Department. Tom holds a BA from Brigham Young University, an M.D. from New York Medical College and an MBA from Harvard Business School. He is also a Kauffman Fellow.

 Session Abstract – PMWC 2020 Silicon Valley

Track 4, January 23

Healthcare diagnostics is at the core of clinical decision making. Early diagnosis can increase the chances of a positive outcome, helping to improve the lives of patients and save payers the costs of further treatment. As health systems move from treatment to prevention, and from volume to value, diagnostics can accelerate this shift. Investment in innovative lab services and technologies is critical in enabling hospitals and healthcare systems to improve efficiencies in the lab, optimize their laboratories to realize gains, and deliver on the imperatives of improving patient outcomes while reducing costs. This session will provide insights from payers that have been actively investing in companies developing innovative lab services and technologies.